Haji-Ghassemi Omid, Müller-Loennies Sven, Saldova Radka, Muniyappa Mohankumar, Brade Lore, Rudd Pauline M, Harvey David J, Kosma Paul, Brade Helmut, Evans Stephen V
From the Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8P 3P6, Canada.
Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Parkallee 22, Borstel D-23845, Germany,
J Biol Chem. 2014 Jun 13;289(24):16644-61. doi: 10.1074/jbc.M113.528224. Epub 2014 Mar 28.
The structure of the antigen binding fragment of mAb S25-26, determined to 1.95 Å resolution in complex with the Chlamydiaceae family-specific trisaccharide antigen Kdo(2→8)Kdo(2→4)Kdo (Kdo = 3-deoxy-α-d-manno-oct-2-ulopyranosonic acid), displays a germ-line-coded paratope that differs significantly from previously characterized Chlamydiaceae-specific mAbs despite being raised against the identical immunogen. Unlike the terminal Kdo recognition pocket that promotes cross-reactivity in S25-2-type antibodies, S25-26 and the closely related S25-23 utilize a groove composed of germ-line residues to recognize the entire trisaccharide antigen and so confer strict specificity. Interest in S25-23 was sparked by its rare high μm affinity and strict specificity for the family-specific trisaccharide antigen; however, only the related antibody S25-26 proved amenable to crystallization. The structures of three unliganded forms of S25-26 have a labile complementary-determining region H3 adjacent to significant glycosylation of the variable heavy chain on asparagine 85 in Framework Region 3. Analysis of the glycan reveals a heterogeneous mixture with a common root structure that contains an unusually high number of terminal αGal-Gal moieties. One of the few reported structures of glycosylated mAbs containing these epitopes is the therapeutic antibody Cetuximab; however, unlike Cetuximab, one of the unliganded structures in S25-26 shows significant order in the glycan with appropriate electron density for nine residues. The elucidation of the three-dimensional structure of an αGal-containing N-linked glycan on a mAb variable heavy chain has potential clinical interest, as it has been implicated in allergic response in patients receiving therapeutic antibodies.
单克隆抗体S25-26的抗原结合片段与衣原体科特异性三糖抗原Kdo(2→8)Kdo(2→4)Kdo(Kdo = 3-脱氧-α-d-甘露糖-辛-2-酮糖醛酸)形成复合物,其结构分辨率为1.95 Å,显示出种系编码的互补决定区,尽管针对相同的免疫原产生,但与先前表征的衣原体科特异性单克隆抗体有显著差异。与促进S25-2型抗体交叉反应的末端Kdo识别口袋不同,S25-26和密切相关的S25-23利用由种系残基组成的凹槽来识别整个三糖抗原,因此具有严格的特异性。S25-23因其对家族特异性三糖抗原罕见的高亲和力和严格特异性而引发关注;然而,只有相关抗体S25-26适合结晶。S25-26的三种未结合配体形式的结构在框架区3中与可变重链天冬酰胺85上的显著糖基化相邻处有一个不稳定的互补决定区H3。聚糖分析显示,其具有共同根结构的异质混合物,其中含有异常高数量的末端αGal-Gal部分。含有这些表位的糖基化单克隆抗体的少数报道结构之一是治疗性抗体西妥昔单抗;然而,与西妥昔单抗不同,S25-26中的一种未结合配体结构在聚糖中显示出显著的有序性,九个残基具有适当的电子密度。阐明单克隆抗体可变重链上含αGal的N-连接聚糖的三维结构具有潜在的临床意义,因为它与接受治疗性抗体的患者的过敏反应有关。